Clinical Trials Browser

Phase 2 × Interventional × HER2-positive Metastatic Breast Cancer × Clear all

NCT06595563 2026-02-19

ZEPHIR-02

Phase 2 Recruiting

HER2-positive Metastatic Breast Cancer

NCT03417544 2025-04-02

Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC

Phase 2 Active not recruiting

19 enrolled 26 charts

HER2-positive Metastatic Breast Cancer

NCT05042791 2024-02-09

A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases

Phase 2 Unknown

HER2-positive Metastatic Breast Cancer